Header Logo
Keywords
Last Name
Institution
Announcement

You can now add alternative names! Click here to add other names that you've published under.

Chun-Yang Fan

Concepts (278)

Concept scores are derived automatically based on a person's publications. Keywords in the their attributed publications are matched to keywords from the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). The strength of a person's concept scores is based not only on the number of corresponding publications, but also how relevant the concepts are to the overall topics of the publications, how long ago the publications were written, whether the person was the first or senior author, and how many other people have written about the topic.Concepts cannot be directly edited. You can help ensure your concepts are accurate by making sure your attributed publications are correct and up-to-date. We recommend checking over your attributed publications list every three to four months.

Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Head and Neck Neoplasms
14
2010
268
1.820
Why?
Carcinoma, Squamous Cell
15
2010
318
1.700
Why?
DNA Methylation
13
2009
548
1.150
Why?
DNA Glycosylases
5
2011
19
1.080
Why?
Gene Silencing
7
2009
119
1.070
Why?
Promoter Regions, Genetic
11
2009
475
1.060
Why?
Mitochondria
3
2011
402
0.530
Why?
DNA Repair
5
2008
193
0.520
Why?
Adaptor Proteins, Signal Transducing
5
2009
197
0.490
Why?
Polymerase Chain Reaction
11
2009
453
0.490
Why?
Kidney Neoplasms
2
2008
177
0.480
Why?
Carcinoma, Non-Small-Cell Lung
2
2007
154
0.470
Why?
DNA, Neoplasm
10
2008
147
0.470
Why?
Nuclear Proteins
5
2009
242
0.470
Why?
Neoplasm Proteins
4
2005
322
0.420
Why?
Laryngeal Neoplasms
3
2007
42
0.400
Why?
Vascular Endothelial Growth Factor A
2
2009
201
0.380
Why?
CpG Islands
3
2008
108
0.380
Why?
Lung Neoplasms
2
2007
606
0.360
Why?
Microsatellite Instability
1
2009
17
0.350
Why?
Fatty Liver
1
2011
127
0.350
Why?
Immunohistochemistry
7
2012
973
0.340
Why?
Mitochondrial Proteins
2
2007
90
0.330
Why?
Receptors, Vascular Endothelial Growth Factor
1
2008
22
0.320
Why?
Port-Wine Stain
1
2008
14
0.320
Why?
Oxygen
1
2011
326
0.310
Why?
O(6)-Methylguanine-DNA Methyltransferase
2
2005
9
0.310
Why?
Genes, p16
3
2005
9
0.300
Why?
Lymph Nodes
2
2007
260
0.300
Why?
DNA, Mitochondrial
4
2011
112
0.290
Why?
N-Glycosyl Hydrolases
1
2007
6
0.290
Why?
DNA-(Apurinic or Apyrimidinic Site) Lyase
1
2007
16
0.290
Why?
Carcinoma, Renal Cell
1
2008
105
0.290
Why?
Skin
3
2010
409
0.290
Why?
Aged
15
2011
9310
0.290
Why?
Adenoma
1
2008
110
0.280
Why?
Mitochondria, Liver
1
2007
70
0.280
Why?
Cisplatin
3
2007
278
0.280
Why?
Proteoglycans
2
2003
80
0.270
Why?
Fibroma
1
2006
39
0.270
Why?
Aged, 80 and over
8
2009
3129
0.250
Why?
Liver
1
2011
1115
0.250
Why?
Middle Aged
16
2011
12069
0.250
Why?
Membrane Glycoproteins
2
2003
240
0.250
Why?
Survival Analysis
5
2009
653
0.250
Why?
Carcinoma, Hepatocellular
1
2007
191
0.240
Why?
Prognosis
7
2007
1942
0.240
Why?
Humans
36
2013
49974
0.240
Why?
DNA Repair Enzymes
1
2004
44
0.240
Why?
Ataxia Telangiectasia
1
2004
6
0.230
Why?
Salivary Ducts
1
2003
3
0.230
Why?
Salivary Gland Neoplasms
1
2003
7
0.230
Why?
Adenocarcinoma, Clear Cell
1
2003
34
0.230
Why?
Receptors, Cytoplasmic and Nuclear
1
2003
64
0.230
Why?
Liver Neoplasms
1
2007
326
0.220
Why?
Obesity
1
2011
1113
0.210
Why?
Adult
14
2011
13236
0.210
Why?
Nitric Oxide Synthase Type III
2
2013
78
0.200
Why?
Female
22
2012
26472
0.200
Why?
Male
21
2012
25241
0.200
Why?
Epigenesis, Genetic
1
2004
374
0.180
Why?
Transcription Factors
1
2003
561
0.180
Why?
Antineoplastic Agents
2
2010
1171
0.170
Why?
Skin Transplantation
2
2010
43
0.170
Why?
Carrier Proteins
4
2005
304
0.160
Why?
Skin Neoplasms
4
2008
488
0.160
Why?
Tumor Suppressor Proteins
2
2011
128
0.150
Why?
Loss of Heterozygosity
2
2008
77
0.150
Why?
DNA Damage
2
2011
301
0.150
Why?
Survival Rate
3
2009
894
0.140
Why?
Neoplasm Invasiveness
4
2007
267
0.130
Why?
Graft Survival
3
2011
150
0.120
Why?
Ki-67 Antigen
2
2011
57
0.120
Why?
Reverse Transcriptase Polymerase Chain Reaction
3
2011
595
0.120
Why?
Calcium-Calmodulin-Dependent Protein Kinases
2
2005
33
0.120
Why?
Algorithms
2
2008
615
0.120
Why?
Immunoenzyme Techniques
4
2013
143
0.120
Why?
Cadherins
2
2005
68
0.120
Why?
Prostatic Neoplasms
2
2008
394
0.120
Why?
Thyroid Neoplasms
2
2007
110
0.120
Why?
Keratosis
2
2003
13
0.110
Why?
Receptors, Cell Surface
1
2013
122
0.100
Why?
Base Sequence
2
2004
643
0.100
Why?
Carcinoma in Situ
2
2003
73
0.100
Why?
Lymphangioma, Cystic
1
2011
10
0.100
Why?
Arteriovenous Malformations
1
2013
67
0.100
Why?
Laryngectomy
3
2007
28
0.100
Why?
Leukoplakia, Oral
1
2011
6
0.100
Why?
Aminolevulinic Acid
1
2011
8
0.100
Why?
Endothelium, Lymphatic
1
2011
12
0.100
Why?
Lasers, Dye
1
2011
9
0.100
Why?
Wound Healing
2
2010
204
0.100
Why?
Antigens, CD
1
2013
219
0.100
Why?
Photosensitizing Agents
1
2011
21
0.100
Why?
Cell Line, Tumor
4
2010
1403
0.100
Why?
Lymphatic Abnormalities
1
2011
22
0.100
Why?
Propranolol
1
2012
78
0.100
Why?
Microtubule-Associated Proteins
1
2011
67
0.100
Why?
Photochemotherapy
1
2011
34
0.100
Why?
Biopsy
3
2011
584
0.100
Why?
Homeodomain Proteins
1
2011
80
0.100
Why?
Taxoids
1
2010
37
0.090
Why?
Laser Therapy
1
2011
84
0.090
Why?
Drug Resistance, Multiple
1
2010
23
0.090
Why?
Hemangioma
1
2012
83
0.090
Why?
Hypoxia-Inducible Factor 1, alpha Subunit
1
2010
56
0.090
Why?
Follow-Up Studies
4
2011
2182
0.090
Why?
Gene Deletion
1
2011
266
0.090
Why?
Neoplasm Staging
3
2007
740
0.090
Why?
Gene Expression Regulation, Neoplastic
4
2010
828
0.090
Why?
Mice, Transgenic
1
2011
555
0.080
Why?
Disease Models, Animal
2
2011
1455
0.080
Why?
Animals
8
2011
13187
0.080
Why?
Drug Resistance, Neoplasm
1
2010
308
0.080
Why?
Sulfites
1
2008
1
0.080
Why?
Paraffin Embedding
1
2008
53
0.080
Why?
Microsatellite Repeats
1
2008
37
0.080
Why?
Blood Glucose
1
2011
439
0.080
Why?
Neoplasm Seeding
1
2008
4
0.080
Why?
Mice
4
2011
5739
0.080
Why?
Chordoma
1
2008
8
0.080
Why?
Antineoplastic Combined Chemotherapy Protocols
2
2004
989
0.080
Why?
Recurrent Laryngeal Nerve
1
2007
13
0.080
Why?
Skull Base Neoplasms
1
2008
21
0.080
Why?
Laryngeal Nerves
1
2007
16
0.080
Why?
Cyclin-Dependent Kinase Inhibitor p16
2
2005
55
0.080
Why?
Receptors, Thyrotropin
1
2007
7
0.080
Why?
Apoptosis Regulatory Proteins
2
2005
86
0.080
Why?
Symporters
1
2007
17
0.080
Why?
Methylation
2
2007
122
0.080
Why?
Pattern Recognition, Automated
1
2007
42
0.070
Why?
Image Enhancement
1
2007
54
0.070
Why?
Risk Factors
3
2008
3613
0.070
Why?
Cell Proliferation
1
2011
1007
0.070
Why?
Precancerous Conditions
1
2008
83
0.070
Why?
Prostate
1
2008
117
0.070
Why?
Carcinoma, Papillary
1
2007
48
0.070
Why?
Transgenes
1
2007
55
0.070
Why?
Neoplasm Recurrence, Local
2
2008
614
0.070
Why?
Child, Preschool
3
2012
3871
0.070
Why?
Image Interpretation, Computer-Assisted
1
2007
106
0.070
Why?
Child
5
2012
6847
0.070
Why?
Cell Nucleus
1
2007
183
0.070
Why?
MicroRNAs
1
2010
353
0.070
Why?
Syndecans
2
2003
34
0.070
Why?
Artificial Intelligence
1
2007
80
0.070
Why?
Protein Transport
1
2007
180
0.070
Why?
RNA, Messenger
2
2007
1105
0.070
Why?
Syndecan-1
2
2003
72
0.070
Why?
Genomics
1
2008
286
0.070
Why?
Adenomatous Polyposis Coli Protein
1
2005
2
0.070
Why?
Receptors, Atrial Natriuretic Factor
1
2005
8
0.060
Why?
Atrial Natriuretic Factor
1
2005
21
0.060
Why?
Ear, Inner
1
2005
17
0.060
Why?
Melanoma
1
2008
285
0.060
Why?
Guanine
1
2004
40
0.060
Why?
Cell Physiological Phenomena
1
2004
3
0.060
Why?
Cell Cycle Proteins
1
2005
166
0.060
Why?
Cytochromes c
1
2003
29
0.060
Why?
DNA Adducts
1
2004
78
0.060
Why?
Salivary Proteins and Peptides
1
2003
8
0.060
Why?
Statistics as Topic
1
2003
88
0.060
Why?
Isoenzymes
1
2003
168
0.060
Why?
Base Pair Mismatch
1
2003
22
0.060
Why?
Adenocarcinoma, Follicular
1
2003
3
0.060
Why?
Adenocarcinoma, Papillary
1
2003
5
0.060
Why?
Tunica Intima
1
2003
54
0.050
Why?
Adenoma, Oxyphilic
1
2003
11
0.050
Why?
Cell Count
1
2003
147
0.050
Why?
Retrospective Studies
4
2007
6108
0.050
Why?
DNA-Binding Proteins
1
2005
427
0.050
Why?
Keratoacanthoma
1
2002
7
0.050
Why?
Collagen
1
2003
206
0.050
Why?
Renal Dialysis
1
2003
169
0.050
Why?
Platelet Aggregation Inhibitors
1
2003
172
0.050
Why?
Alcohol Drinking
1
2003
224
0.050
Why?
Combined Modality Therapy
4
2004
637
0.050
Why?
Lung
1
2005
486
0.050
Why?
Molecular Sequence Data
1
2003
792
0.050
Why?
Adolescent
2
2012
6356
0.050
Why?
Blotting, Western
2
2013
601
0.050
Why?
Cohort Studies
1
2005
1422
0.050
Why?
Blood Platelets
1
2003
245
0.050
Why?
Prevalence
1
2004
944
0.050
Why?
Tomography, X-Ray Computed
1
2006
1159
0.050
Why?
Smoking
1
2003
511
0.040
Why?
Random Allocation
2
2010
281
0.040
Why?
Quality of Life
1
2004
836
0.040
Why?
Electrophoresis, Agar Gel
2
2008
11
0.040
Why?
Sensitivity and Specificity
2
2010
861
0.040
Why?
Hyperplasia
2
2008
96
0.030
Why?
Neck Dissection
2
2008
31
0.030
Why?
Dose-Response Relationship, Drug
2
2011
1376
0.030
Why?
Fluorouracil
2
2004
54
0.030
Why?
Photosensitivity Disorders
2
2003
10
0.030
Why?
Cross-Sectional Studies
2
2012
1557
0.030
Why?
Infant
2
2012
3567
0.030
Why?
Lymph Node Excision
2
2004
134
0.030
Why?
Head
1
2013
73
0.030
Why?
Actins
1
2013
118
0.030
Why?
Neck
1
2013
99
0.030
Why?
Treatment Outcome
3
2011
5141
0.030
Why?
Lymphocele
1
2011
7
0.030
Why?
Tissue Survival
1
2011
10
0.030
Why?
Antigens, Nuclear
1
2011
24
0.030
Why?
Antibodies, Monoclonal, Murine-Derived
1
2011
47
0.020
Why?
Administration, Topical
1
2011
56
0.020
Why?
Tissue Culture Techniques
1
2011
40
0.020
Why?
Transplantation, Heterologous
1
2011
74
0.020
Why?
Time Factors
2
2010
2903
0.020
Why?
Mice, Nude
1
2011
252
0.020
Why?
Neoplasms, Squamous Cell
1
2010
7
0.020
Why?
Rats
2
2009
3305
0.020
Why?
Granulation Tissue
1
2010
10
0.020
Why?
Pharmacogenetics
1
2010
52
0.020
Why?
Tissue and Organ Harvesting
1
2010
23
0.020
Why?
Myeloid Cells
1
2010
38
0.020
Why?
Probability
1
2010
164
0.020
Why?
Endothelial Cells
1
2011
269
0.020
Why?
Carcinoma
1
2010
138
0.020
Why?
Graft Rejection
1
2010
161
0.020
Why?
Pilot Projects
1
2011
699
0.020
Why?
Neovascularization, Physiologic
1
2009
68
0.020
Why?
Thymine
1
2008
10
0.020
Why?
Chi-Square Distribution
1
2009
280
0.020
Why?
Centromere
1
2008
11
0.020
Why?
Microdissection
1
2008
19
0.020
Why?
Cell Line, Transformed
1
2008
72
0.020
Why?
Telomere
1
2008
36
0.020
Why?
Melanocytes
1
2008
37
0.020
Why?
Gene Dosage
1
2008
78
0.020
Why?
Fluorescent Dyes
1
2008
102
0.020
Why?
Iodine
1
2007
10
0.020
Why?
Genetic Markers
1
2008
102
0.020
Why?
Predictive Value of Tests
1
2010
903
0.020
Why?
Mice, Knockout
1
2010
841
0.020
Why?
Fatal Outcome
1
2008
195
0.020
Why?
Cluster Analysis
1
2007
235
0.020
Why?
Epithelial Cells
1
2008
209
0.020
Why?
Buffers
1
2005
9
0.020
Why?
Prospective Studies
1
2011
2364
0.020
Why?
Round Window, Ear
1
2005
6
0.020
Why?
Injections
1
2005
55
0.020
Why?
Rats, Inbred Lew
1
2005
69
0.020
Why?
Phosphates
1
2005
47
0.020
Why?
Sodium Chloride
1
2005
57
0.020
Why?
Rats, Sprague-Dawley
1
2009
1597
0.020
Why?
Protein Isoforms
1
2005
119
0.020
Why?
Drug Combinations
1
2005
123
0.020
Why?
Mice, Inbred C57BL
1
2010
1816
0.020
Why?
Antibodies
1
2005
154
0.020
Why?
Statistics, Nonparametric
1
2004
194
0.010
Why?
Reproducibility of Results
1
2007
1193
0.010
Why?
Disease-Free Survival
1
2005
454
0.010
Why?
Platelet Adhesiveness
1
2003
13
0.010
Why?
Elastin
1
2003
23
0.010
Why?
Polytetrafluoroethylene
1
2003
32
0.010
Why?
DNA Primers
1
2003
207
0.010
Why?
Up-Regulation
1
2005
452
0.010
Why?
Anastomosis, Surgical
1
2003
66
0.010
Why?
Radiotherapy
1
2004
128
0.010
Why?
Vascular Patency
1
2003
82
0.010
Why?
Dogs
1
2003
182
0.010
Why?
Radiotherapy, Adjuvant
1
2003
56
0.010
Why?
Myocytes, Smooth Muscle
1
2003
86
0.010
Why?
Chemotherapy, Adjuvant
1
2003
119
0.010
Why?
Graft Occlusion, Vascular
1
2003
73
0.010
Why?
Extracellular Matrix
1
2003
111
0.010
Why?
Thyroidectomy
1
2003
59
0.010
Why?
Biopsy, Needle
1
2003
183
0.010
Why?
Young Adult
1
2012
3958
0.010
Why?
Lymphatic Metastasis
1
2003
224
0.010
Why?
Stromal Cells
1
2002
72
0.010
Why?
Models, Biological
1
2003
727
0.010
Why?
Risk Assessment
1
2003
1259
0.010
Why?
Arkansas
1
2004
1977
0.010
Why?
Diagnosis, Differential
1
2002
1037
0.010
Why?
Pregnancy
1
2003
2607
0.010
Why?
Fan's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
_
Co-Authors Expand Description
_
Similar People Expand Description
_
Same Department Expand Description